Rob Hughes, C.P.A., M.B.A., is Senior Vice President of Finance and Administration at StrideBio. An accomplished financial executive with over 20 years of experience working in both public and private companies, he brings an in-depth understanding of corporate finance and has expertise in equity financing, strategic planning, financial analysis, acquisitions and corporate operations.
Prior to StrideBio, Mr. Hughes was the Senior Vice President of Finance at Selenity Therapeutics, a pre-clinical pharmaceutical discovery and development company. Prior to Selenity, Mr. Hughes was the Vice President of Finance at Viamet Pharmaceuticals, a clinical-stage pharmaceutical company acquired by NovaQuest Capital Management in 2018.
Mr. Hughes is a C.P.A. and holds a B.S. from the University of Maryland, where he majored in Finance and Accounting. He also holds an M.B.A. from the University of North Carolina.